Davis WA, Norman PE, Bruce DG, et al: Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. .Diabetologia 49::2634. ,2006. .
Centers for Disease Control and Prevention (CDC): National Diabetes Fact Sheet. Available at: http://apps.nccd.cdc.gov/DDTSTRS/default.aspx. Accessed July 8. ,2010. .
American Diabetes Association (ADA): Economic costs of diabetes in the U.S. 2007. .Diabetes Care 31::596. ,2008. .
Connor H: Some historical aspects of diabetic foot disease. .Diabetes Metab Res Rev 24: (suppl 1):S7. ,2008. .
Pecoraro RE, Reiber GE, Burgess EM: Pathways to diabetic limb amputation: basis for prevention. .Diabetes Care 13::513. ,1990. .
Holzer SE, Camerota A, Martens L, et al: Costs and duration of care for lower extremity ulcers in patients with diabetes. .Clin Ther 20::169. ,1998. .
Harrington C, Zagari MJ, Corea J, et al: A cost analysis of diabetic lower-extremity ulcers. .Diabetes Care 23::1333. ,2000. .
Ramsey SD, Newton K, Blough D, et al: Incidence, outcomes, and cost of foot ulcers in patients with diabetes. .Diabetes Care 22::382. ,1999. .
Apelqvist J, Ragnarson-Tennvall G, Persson U, et al: Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. .J Intern Med 235::463. ,1994. .
Apelqvist J, Ragnarson-Tennvall G, Larsson J, et al: Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. .Foot Ankle Int 16::388. ,1995. .
Stockl K, Vanderplas A, Tafesse E, et al: Costs of lower-extremity ulcers among patients with diabetes. .Diabetes Care 27::2129. ,2004. .
Reiber GE, Boyko EJ, Smith DG: “Lower Extremity Foot Ulcers and Amputations in Diabetes,” in Diabetes in America, 2nd Ed, ed by M Harris, p 409, National Institutes of Health, Bethesda, MD. ,1995. .
Eslami MH, Zayaruzny M, Fitzgerald GA: The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia. .J Vasc Surg 45::55. ,2007. .
LoGerfo FW, Gibbons GW, Pomposelli FB Jr, et al: Trends in the care of the diabetic foot: expanded role of arterial reconstruction. .Arch Surg 127::617. ,1992. .
Gibbons GW, Marcaccio EJ Jr, Burgess AM, et al: Improved quality of diabetic foot care, 1984 vs 1990: reduced length of stay and costs, insufficient reimbursement. .Arch Surg 128::576. ,1993. .
Faglia E, Mantero M, Caminiti M, et al: Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. .J Intern Med 252::225. ,2002. .
Zayed H, Halawa M, Maillardet L, et al: Improving limb salvage rate in diabetic patients with critical leg ischemia using a multidisciplinary approach. .Int J Clin Pract 63::855. ,2009. .
Larsson J, Apelqvist J, Agardh CD, et al: Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach?. Diabet Med 12::770. ,1995. .
Van Gils CC, Wheeler LA, Mellstrom M, et al: Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients: the Operation Desert Foot experience. .Diabetes Care 22::678. ,1999. .
Driver VR, Madsen J, Goodman RA: Reducing amputation rates in patients with diabetes at a military medical center: the limb preservation service model. .Diabetes Care 28::248. ,2005. .
Krishnan S, Nash F, Baker N, et al: Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. .Diabetes Care 31::99. ,2008. .
Anichini R, Zecchini F, Cerretini I, et al: Improvement of diabetic foot care after the implementation of the International Consensus on the Diabetic Foot (ICDF): results of a 5-year prospective study. .Diabetes Res Clin Pract 75::153. ,2007. .
Ragnarson Tennvall G, Apelqvist J: Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. .Diabetologia 44::2077. ,2001. .
Ollendorf DA, Kotsanos JG, Wishner WJ, et al: Potential economic benefits of lower-extremity amputation prevention strategies in diabetes. .Diabetes Care 21::1240. ,1998. .
Ortegon MM, Redekop WK, Niessen LW: Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. .Diabetes Care 27::901. ,2004. .
Horswell RL, Birke JA, Patout CA Jr: A staged management diabetes foot program versus standard care: a 1-year cost and utilization comparison in a state public hospital system. .Arch Phys Med Rehabil 84::1743. ,2003. .
Matricali GA, Dereymaeker G, Muls E, et al: Economic aspects of diabetic foot care in a multidisciplinary setting: a review. .Diabetes Metab Res Rev 23::339. ,2007. .
In 2007, the treatment of diabetes and its complications in the United States generated at least $116 billion in direct costs; at least 33% of these costs were linked to the treatment of foot ulcers. Although the team approach to diabetic foot problems is effective in preventing lower-extremity amputations, the costs associated with implementing a diabetic-foot–care team are not well understood. An analysis of these costs provides the basis for this report.
Diabetic foot problems impose a major economic burden, and costs increase disproportionately to the severity of the condition. Compared with diabetic patients without foot ulcers, the cost of care for those with foot ulcers is 5.4 times higher in the year after the first ulcer episode and 2.8 times higher in the second year. Costs for treating the highest-grade ulcers are 8 times higher than are those for treating low-grade ulcers. Patients with diabetic foot ulcers require more frequent emergency department visits and are more commonly admitted to the hospital, requiring longer lengths of stay. Implementation of the team approach to manage diabetic foot ulcers in a given region or health-care system has been reported to reduce long-term amputation rates 62% to 82%. Limb salvage efforts may include aggressive therapy such as revascularization procedures and advanced wound-healing modalities. Although these procedures are costly, the team approach gradually leads to improved screening and prevention programs and earlier interventions and, thus, seems to reduce long-term costs.
To date, aggressive limb preservation management for patients with diabetic foot ulcers has not usually been paired with adequate reimbursement. It is essential to direct efforts in patient-caregiver education to allow early recognition and management of all diabetic foot problems and to build integrated pathways of care that facilitate timely access to limb salvage procedures. Increasing evidence suggests that the costs of implementing diabetic foot teams can be offset in the long term by improved access to care and reductions in foot complications and amputation rates. (J Am Podiatr Med Assoc 100(5): 335–341, 2010)